H. Leblanc

发表

Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in Type 1 (insulin-dependent) diabetic patients

D. Darmaun, J. Robert, D. Chauvet, 1993, Diabetologia.

Are the implications of the Diabetes Control and Complications Trial (DCCT) feasible in daily clinical practice?

J. Gautier, P. Passa, J. Beressi, 1996, Diabetes & metabolism.

The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observations of biological action of somatostatin.

B. Lasley, S. Yen, S S Yen, 1975, Recent progress in hormone research.

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

J. Ménard, G. Chatellier, M. Marre, 1988, BMJ.

Clinical Use of Continuous Glucose Clinical Use of Continuous Glucose Monitoring and Ambulatory Glucose Monitoring and Ambulatory Glucose Profile in Type 1 Diabetes Patients on Profile in Type 1 Diabetes Patients on Multiple Daily Injections Multiple Daily Injections

D. Owens, E. Renard, M. Massi-Benedetti, 2014 .

Effects of dopamine infusion on pituitary hormone secretion in humans.

S. Yen, H. Leblanc, S. Yen, 1976, The Journal of clinical endocrinology and metabolism.

Detection of coronary artery disease in diabetic patients

J. Ruiz, J. Juliard, P. Passa, 1995, Diabetologia.

Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.

J. Ruiz, P. Passa, D. Chevenne, 1994, Clinical chemistry.

Prevalence and risk factors of diabetes mellitus in the rural region of Mali (West Africa): a practical approach

G. Brücker, T. Prazuck, H. Leblanc, 1987, Diabetologia.

Effects of Enalapril in Insulin-Dependent Diabetic Subjects With Mild to Moderate Uncomplicated Hypertension

M. Marre, P. Passa, H. Leblanc, 1987, Diabetes Care.

The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.

S. Yen, H. Leblanc, F. Ward, 1975, The Journal of clinical endocrinology and metabolism.

Glucagon secretion in late pregnancy and the puerperium.

S. Yen, J. Anderson, H. Leblanc, 1976, American journal of obstetrics and gynecology.

Metabolic and immunogenetic prediction of long‐term insulin remission in African patients with atypical diabetes

J. Mbanya, J. Gautier, E. Sobngwi, 2002, Diabetic medicine : a journal of the British Diabetic Association.

The inhibitory effect of dopamine agonists on LH release in women.

S. Yen, H. Leblanc, G. Lachelin, 1977, The Journal of clinical endocrinology and metabolism.

Pump Insulin Pump T Tr r eatment in eatment in T T ype 2 Diabetes ype 2 Diabetes

D. Owens, E. Renard, M. Massi-Benedetti, 2008 .

Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001.

B. Guerci, H. Hanaire, V. Sulmont, 2011, Diabetes & metabolism.

Inhibitory Action of Somatostatin on Pancreatic α and β Cell Function1

S. Yen, J. Anderson, H. Leblanc, 1975 .

Comparison of Cyclic and Linear Forms of Somatostatin in the Inhibition of Growth Hormone, Insulin and Glucagon Secretion1

S. Yen, H. Leblanc, 1975 .

The response of pancreatic and pituitary hormones to pulses and constant infusion of somatostatin.

S. Yen, H. Leblanc, L. Rigg, 1975, The Journal of clinical endocrinology and metabolism.

The effect of dopamine infusion on insulin and glucagon secretion in man.

S. Yen, H. Leblanc, S. Abu-fadil, 1977, The Journal of clinical endocrinology and metabolism.

[Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics].

G. Chatellier, P. Passa, H. Leblanc, 1990, Diabete & metabolisme.

Assessment of the level of Assessment of the level

D. Owens, E. Renard, M. Massi-Benedetti, 2007 .

Erythrocyte adhesion to cultured endothelium and glycaemic control in Type I (insulin-dependent) diabetic patients

E. Abadie, J. Wautier, P. Passa, 1986, Diabetologia.

Discontinuing ACE inhibition in patients with diabetic nephropathy.

P. Passa, H. Leblanc, J. Ménard, 1991, BMJ.

Non-invasive identification of severe coronary artery disease in patients with long-standing diabetes mellitus.

P. Steg, J. Juliard, P. Passa, 1992, The European journal of medicine.

Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

M. Marre, L. Suarez, P. Passa, 1987, British medical journal.

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

Gilberto Velho, Hervé Leblanc, Raphaël Porcher, 2003, The Lancet.

Suitability of reflectometry in epidemiology of diabetes mellitus in Africans

T. Prazuck, H. Leblanc, E. Pichard, 1990, The Lancet.

The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.

S. Yen, H. Leblanc, 1976, American journal of obstetrics and gynecology.

Marital status and family size of type 1 diabetic patients in a French cohort.

J. Gautier, E. Sobngwi, P. Vexiau, 2003, Diabetes & metabolism.

Glycemic Control with Closed-Loop Intraperitoneal Insulin in Type I Diabetes

J. Robert, P. Lombrail, D. Chauvet, 1986, Diabetes Care.

[Relation between urinary albumin excretion and retinopathy in insulin-dependent diabetics].

M. Marre, P. Passa, H. Leblanc, 1986, Presse medicale.

Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group.

J. Rouland, G. Slama, B. Charbonnel, 1997, Diabetes & Metabolism.

[Silent myocardial ischemia in diabetics. Detection--prognostic and therapeutic implications].

P. Passa, F. Paycha, C. Paillole, 1989, Diabete & metabolisme.

ENALAPRIL, CAPTOPRIL, AND BLOOD GLUCOSE

M. Marre, P. Passa, H. Leblanc, 1986, The Lancet.

Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion.

S. Yen, H. Leblanc, 1975, The Journal of clinical endocrinology and metabolism.